Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MIRVALA 21 0.1500 MG

DESOGESTREL : 0.1500 MG ETHINYL ESTRADIOL : 0.0300 MG · DIN 02410249 · APOTEX INC

Health Canada status: MARKETED

What is MIRVALA 21?

MIRVALA 21 0.1500 MG contains DESOGESTREL : 0.1500 MG ETHINYL ESTRADIOL : 0.0300 MG. It is listed in the Health Canada Drug Product Database under DIN 02410249, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 07-Jan-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is MIRVALA 21 used for?

Conception control

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02410249
Brand nameMIRVALA 21
Generic / active ingredientDESOGESTREL : 0.1500 MG ETHINYL ESTRADIOL : 0.0300 MG
ManufacturerAPOTEX INC
Strength0.1500 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeG03AA09 DESOGESTREL AND ESTROGEN
AHFS class68:12.00
BiosimilarNo
Health Canada statusMARKETED
Status date07-Jan-2014
Original market date2014-01-07 00:00:00

How is it stored and handled?

null

How is it supplied?

MIRVALA 21: Push-through strips of 21 white tablets each. The push-through strip consists of PVC-PVDC/aluminium blisters. MIRVALA 28: Push-through strips of 21 white and 7 green tablets each. The push-through strip consists of PVC-PVDC/aluminium blisters.

What can be used instead?

Other Canadian products sharing ATC code G03AA09 DESOGESTREL AND ESTROGEN. 10 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
APRI 210.03 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 02317192
APRI 280.15 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 02317206
FREYA 210.15 MGTABLETMYLAN PHARMACEUTICALS ULCMARKETEDDIN 02396491
FREYA 280.03 MGTABLETMYLAN PHARMACEUTICALS ULCMARKETEDDIN 02396610
MARVELON 210.03 MGTABLETORGANON CANADA INC.MARKETEDDIN 02042487
MARVELON 280.15 MGTABLETORGANON CANADA INC.MARKETEDDIN 02042479
MILEY 210.15 MGTABLETAMBICARE PHARMACEUTICALS INC.MARKETEDDIN 02556553
MILEY 280.15 MGTABLETAMBICARE PHARMACEUTICALS INC.MARKETEDDIN 02556561
MIRVALA 280.0300 MGTABLETAPOTEX INCMARKETEDDIN 02410257
MARFEM 210.03 MGTABLETNOVOPHARM LIMITEDCANCELLED PRE MARKETDIN 02328828

Who else supplies DESOGESTREL AND ESTROGEN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. DESOGESTREL AND ESTROGEN appears in 87 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for MIRVALA 21

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for MIRVALA 21

Health Canada Drug Product Database (DPD), DIN 02410249. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.